Combining risk factors with faecal immunochemical test outcome for selecting CRC screenees for colonoscopy

Gut

Volumn 63, Issue 3, 2014, Pages 466-471

  Stegeman, Inge ^a,b   De Wijkerslooth, Thomas R ^a   Stoop, Esther M ^c   Van Leerdam, Monique E ^c   Dekker, Evelien ^a   Van Ballegooijen, Marjolein ^c   Kuipers, Ernst J ^c   Fockens, Paul ^a   Kraaijenhagen, Roderik A ^b   Bossuyt, Patrick M ^a  

^a ACADEMIC MEDICAL CENTER   (Netherlands)

^b NDDO Institute for Prevention and Early Diagnostics   (Netherlands)

^c ERASMUS MEDICAL CENTER   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

CANCER EPIDEMIOLOGY; CANCER PREVENTION; COLORECTAL CANCER; SCREENING;

AGED; COLONOSCOPY; COLORECTAL NEOPLASMS; DECISION SUPPORT TECHNIQUES; EARLY DETECTION OF CANCER; FECES; FEMALE; HUMANS; LOGISTIC MODELS; MALE; MIDDLE AGED; MULTIVARIATE ANALYSIS; QUESTIONNAIRES; RISK ASSESSMENT; RISK FACTORS; ROC CURVE;

EID: 84893430714     PISSN: 00175749     EISSN: 14683288     Source Type: Journal    
DOI: 10.1136/gutjnl-2013-305013     Document Type: Article

References (27)

1. Dashwood RH. Early detection and prevention of colorectal cancer (review). Oncol Rep 1999;6:277-81.
2. Ferlay J, Parkin DM, Steliarova-Foucher E. Estimates of cancer incidence and mortality in Europe in 2008. Eur J Cancer 2010;46:765-81.
3. Winawer SJ, Zauber AG, Ho MN, et al. Prevention of colorectal cancer by colonoscopic polypectomy. The National Polyp Study Workgroup. N Engl J Med 1993;329:1977-81. (Pubitemid 24015040)
4. van Turenhout ST, Terhaar sive Droste JS, Meijer GA, et al. Anticipating implementation of colorectal cancer screening in The Netherlands: a nation wide survey on endoscopic supply and demand. BMC Cancer 2012;12:46.
5. de Wijkerslooth TR, de Haan MC, Stoop EM, et al. Burden of colonoscopy compared to non-cathartic CT-colonography in a colorectal cancer screening programme: randomised controlled trial. Gut 2012;61:1552-9.
6. de wijkerslooth TR, Stoop EM, Bossuyt PM, et al. Immunochemical fecal occult blood testing is equally sensitive for proximal and distal advanced neoplasia. Am J Gastroenterol 2012;107:1570-8.
7. Anderson JC, Alpern Z, Sethi G, et al. Prevalence and risk of colorectal neoplasia in consumers of alcohol in a screening population. Am J Gastroenterol. 2005;100:2049-55.
8. Moskal A, Norat T, Ferrari P, et al. Alcohol intake and colorectal cancer risk: a dose-response meta-analysis of published cohort studies. Int J Cancer 2006;120:664-71.
9. Colditz GA, Atwood KA, Emmons K, et al. Harvard report on cancer prevention volume 4: Harvard Cancer Risk Index. Risk Index Working Group, Harvard Center for Cancer Prevention. Cancer Causes Control 2000;11:477-88. (Pubitemid 30342837)
10. de Wijkerslooth TR, de Haan MC, Stoop EM, et al. Study protocol: population screening for colorectal cancer by colonoscopy or CT colonography: a randomized controlled trial. BMC Gastroenterol 2010;10:47.
11. Stoop EM, de Haan MC, de Wijkerslooth TR, et al. Participation and yield of colonoscopy versus non-cathartic CT colonography in population-based screening for colorectal cancer: a randomised controlled trial. Lancet Oncol 2012; 13:55-64.
12. Stegeman I, de Wijkerslooth TR, Stoop EM, et al. Colorectal cancer risk factors in the detection of advanced adenoma and colorectal cancer. Cancer Epidemiol 2013;37:278-83.
13. Nagengast FM, Kaandorp CJ, CBO-werkgroep. [Revised CBO guideline 'Follow-up after polypectomy']. Ned Tijdschr Geneeskd 2001;145:2022-5. (Pubitemid 32979472)
14. Schlemper RJ, Riddell RH, Kato Y, et al. The Vienna classification of gastrointestinal epithelial neoplasia. Gut 2000;47:251-5. (Pubitemid 30489769)
15. Streiner DL. The case of the missing data: methods of dealing with dropouts and other research vagaries. Can J Psychiatry 2002;47:68-75. (Pubitemid 34298252)
16. Donders ART, van der Heijden GJMG, Stijnen T, et al. Review: a gentle introduction to imputation of missing values. J Clin Epidemiol 2006;59:1087-91. (Pubitemid 44374314)
17. Steyerberg EW. Clinical prediction models. Springer Verlag, 2009.
18. Steyerberg EW, Vickers AJ, Cook NR, et al. Assessing the performance of prediction models. Epidemiology 2010;21:128-38.
19. Pepe MS, Feng Z, Huang Y, et al. Integrating the predictiveness of a marker with its performance as a classifier. Am J Epidemiol 2007;167:362-8. (Pubitemid 351197592)
20. Pencina MJ, D' Agostino RB, D' Agostino RB, et al. Evaluating the added predictive ability of a new marker: from area under the ROC curve to reclassification and beyond. Statist Med 2007;27:157-72. (Pubitemid 351193639)
21. Scott RG, Edwards JT, Fritschi L, et al. Community-based screening by colonoscopy or computed tomographic colonography in asymptomatic average-risk subjects. Am J Gastroenterol 2004;99:1145-51. (Pubitemid 38917822)
22. Freedman AN, Slattery ML, Ballard-Barbash R, et al. Colorectal cancer risk prediction tool for white men and women without known susceptibility. Int J Clin Oncol 2009;27:686-93.
23. Park Y, Freedman AN, Gail MH, et al. Validation of a colorectal cancer risk prediction model among white patients age 50 years and older. Int J Clin Oncol 2009;27:694-8.
24. Driver JA, Gaziano JM, Gelber RP, et al. Development of a risk score for colorectal cancer in men. Am J Med 2007;120:257-63. (Pubitemid 46341164)
25. Cairns SR, Scholefield JH, Steele RJ, et al. Guidelines for colorectal cancer screening and surveillance in moderate and high risk groups (update from 2002). Gut 2010;59:666-89.
26. Ferlitsch M, Reinhart K, Pramhas S, et al. Sex-specific prevalence of adenomas, advanced adenomas, and colorectal cancer in individuals undergoing screening colonoscopy. JAMA 2011;306:1352-8.
27. Kolligs FT, Crispin A, Munte A, et al. Risk of advanced colorectal neoplasia according to age and gender. PLoS ONE 2011;6:e20076.